Literature DB >> 15172436

Genomic variants among human cytomegalovirus (HCMV) clinical isolates: the glycoprotein n (gN) paradigm.

Paola Dal Monte1, Sara Pignatelli, Giada Rossini, Maria Paola Landini.   

Abstract

Human cytomegalovirus (HCMV) clinical isolates display genetic polymorphisms, which are supposed to be implicated in strain-specific tissue tropism and HCMV-induced immunopathogenesis. One highly variable gene is ORF UL73, encoding for the envelope glycoprotein gN, which displays both a structural and an immunologic role as a component of the high-molecular weight complex gC-II. UL73 showed clustered polymorphisms, which originate four distinct genomic variants, denoted gN-1, gN-2, gN-3, and gN-4. This review reports the main features of gN genotypes and their potential implications on HCMV biologic properties. The clinical impact of gN variants is also discussed. This overview on gN clustered polymorphisms should be useful as a prototype model for a better understanding of the biologic and clinical relevance of HCMV clinical isolates genetic variability.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15172436     DOI: 10.1016/j.humimm.2004.02.023

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  3 in total

1.  Deciphering the Potential Coding of Human Cytomegalovirus: New Predicted Transmembrane Proteome.

Authors:  Francisco J Mancebo; Marcos Parras-Moltó; Estéfani García-Ríos; Pilar Pérez-Romero
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

2.  High genotypic diversity and a novel variant of human cytomegalovirus revealed by combined UL33/UL55 genotyping with broad-range PCR.

Authors:  Merlin Deckers; Jörg Hofmann; Karl-Anton Kreuzer; Henrike Reinhard; Abigail Edubio; Hartmut Hengel; Sebastian Voigt; Bernhard Ehlers
Journal:  Virol J       Date:  2009-11-26       Impact factor: 4.099

Review 3.  Envelope-receptor interactions in Nipah virus pathobiology.

Authors:  Benhur Lee
Journal:  Ann N Y Acad Sci       Date:  2007-04       Impact factor: 5.691

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.